111 Huntington Avenue,
Boston , MA, 02199

Rank

Rank Universe
34 64

Summary

The fund seeks capital appreciation by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in equity securities which include common stocks and other securities that represent an owners More

Link

Directors

Jan 11, 2024
  • Steven E. Buller
  • Maryanne L. Roepke
  • John A. Caroselli
  • James W. Kilman, Jr.
  • Clarence Otis, Jr.
  • Michael W. Roberge
  • John P. Kavanaugh
  • Maureen R. Goldfarb
  • Peter D. Jones
  • Laurie J. Thomsen

Chief Compliance Officer

  • Rosa E. Licea-Mailloux

Fund Manager(s)

Price

  • $ 48.23 ( -0.11 )
    Nov 4, 2024
    Last Close
  • Net Assets
  • $2.6B
    Mar 26, 2024
  • Holding
  • 86
    Sep 25, 2024
    More

  • 52-Week High/Low
  • $49.92 - $43.69
  • Turnover
  • 8%
  • Expense Ratio
  • 1.46%

Company Name

Holding

Visa, Inc. 2.8 %
Thermo Fisher Scientific, Inc. 2.63 %
Schneider Electric SE 2.51 %
Roche Holding AG 2.37 %
Alphabet, Inc. 2.27 %
Charles Schwab Corp. (The) 2.25 %
Willis Towers Watson plc 2.23 %
Medtronic plc 2.19 %
Comcast Corp. 2.09 %
Oracle Corp. 2.07 %
More 2.07 %

Documents

Prospectus

Annual Reports

Performance

YTD

0.1%

3 Year

-18.97%

5 Year

7.58%

Best

30.88%

2009

Worst

-33.94%

2008

Alpha

MEQRX S&P 500

Chart +